1 document found, page 1 of 1
Sort by
Issue Date
Clinical validation of a urine test (uromonitor-V2(®)) for the surveillance of ...
Sieverink, CA; Batista, R; Prazeres, H; Vinagre, J; Sampaio, C; Leão, RR; Máximo, V; Alfred Witjes, J; Soares, PThe costly and burdensome nature of the current follow-up methods in non-muscle-invasive bladder cancer (NMIBC) drives the development of new methods that may alternate with regular cystoscopy and urine cytology. The Uromonitor-V2® is a new urine-based assay in the detection of hotspot mutations in three genes (TERT, FGFR3, and KRAS) for evaluation of disease recurrence. The aim of this study was to investigate...
Date: 2020
|
Origin: Repositório Aberto da Universidade do Porto